Yessar Hussain

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 250 citations

Medicine, Pharmacotherapy, Pain Management +2

Trial of Intravenous Immune Globulin in Dermatomyositis

Rohit Aggarwal, Christina Charles‐Schoeman, Joachim Schessl et al. · New England Journal of Medicine · 2022 · 206 citations · Full text

Medicine, Dermatology, Pharmacotherapy +12

Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial

Jeffrey A. Allen, Jie Lin, Ivana Basta et al. · The Lancet Neurology · 2024 · 96 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +8

Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

Andrew L. Mammen, Anthony A. Amato, Mazen M. Dimachkie et al. · The Lancet Rheumatology · 2023 · 55 citations · Full text

Medicine, Immunology, Pathology +11

Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)

Richard J. Barohn, Byron J. Gajewski, Mamatha Pasnoor et al. · JAMA Neurology · 2020 · 47 citations · Full text

Medicine, Neurology, Pharmacology +17